post-traumatic stress disorder
Coverage of post-traumatic stress disorder in the Nexus archive.
- North Carolina veteran describes ibogaine as a turning point in life after war
A North Carolina veteran described ibogaine as a turning point in his life after serving in the Army during Afghanistan and Iraq wars. He sought psychedelic-assisted therapy through Veterans Exploring Treatment Solutions (VETS) and received treatment in Mexico, where ibogaine is available despite being illegal in the U.S.
- Several women who dated Graham Platner recall his ‘unsettling’ behavior.
Graham Platner, a combat veteran, has been described by several women who dated him as exhibiting unsettling behavior. He has publicly discussed his past struggles with post-traumatic stress disorder, depression, and drinking, stating his past behavior does not reflect his current self.
- AOC dodges questions on abuse allegations, Nazi tattoo claims rocking Platner's campaign
Rep. Alexandria Ocasio-Cortez has not commented on new allegations against Maine Senate candidate Graham Platner, including claims of aggressive behavior and a Nazi-associated tattoo. Multiple women allege Platner engaged in explicit messaging while married, violent incidents, and expressed violent fantasies. Platner acknowledged past struggles with PTSD and alcohol use but disputes the tattoo's Nazi connotations.
- ‘He hated women’: Explosive abuse, new Nazi tattoo allegations from exes rock Platner's campaign
Maine Senate candidate Graham Platner faces allegations from ex-girlfriends, including rape fantasies, violent behavior, and a Nazi-linked tattoo. Platner acknowledges past struggles with PTSD and alcohol but denies further misconduct, calling criticisms politically motivated.
- Several Women Who Dated Graham Platner Recall ‘Unsettling’ Behavior
Several women who dated Graham Platner recall 'unsettling' behavior. Platner, a combat veteran, has discussed past struggles with post-traumatic stress disorder, depression, and drinking, stating his behavior years ago does not reflect his current self.
- FDA moves to fast-track review of 3 psychedelic drug studies
The FDA granted fast-track review to three companies studying psychedelic therapies for depression and PTSD, with two focusing on psilocybin for treatment-resistant depression and major depressive disorder. This move aligns with the Trump administration's push for potential approval of psychedelic treatments.
- FDA grants quick review for 3 psychedelic drug trials
The FDA has expedited the review of three experimental psychedelic drugs intended to treat major depression and post-traumatic stress disorder. NBC News' Erika Edwards highlights the FDA's evaluation process for safety and efficacy of these drugs.
- Watch: Trump signs executive order easing U.S. restrictions on psychedelic research
President Trump signed an executive order to ease U.S. restrictions on psychedelic research, including ibogaine, a drug used in some countries to treat post-traumatic stress disorder.
- Trump announces reforms to accelerate access to psychedelic drug treatments
President Donald Trump signed an executive order directing the FDA to expedite the review of psychedelic drugs like ibogaine, which U.S. military veteran groups claim can treat post-traumatic stress disorder (PTSD). The reform aims to accelerate access to medical research and treatment involving psychedelic substances.
- Trump 'to sign executive order' that will ease access to psychedelic drug used to treat PTSD
Donald Trump is reportedly set to sign an executive order aimed at easing access to a psychedelic drug for treating post-traumatic stress disorder (PTSD). The move seeks to streamline regulatory barriers for patients seeking alternative therapies.